Dapagliflozin for Atrial Fibrillation Na LiMihail G. CheluYochai Birnbaum Invited Editorial 06 February 2024 Pages: 1 - 3
P2Y12 Inhibitors in STEMI Patients — One Size Does Not Fit All Rajiv C. PatelJeffrey E. JonesGeorge A. Stouffer Invited Editorial 02 August 2023 Pages: 5 - 7
High BMI: Another Barrier to Rapid Platelet Inhibition After STEMI PCI Kenneth M. ZabelJames C. Blankenship Editorial 18 August 2023 Pages: 9 - 11
Differential Proteomic Profiles of Coronary Serum Exosomes in Acute Myocardial Infarction Patients with or Without Diabetes Mellitus: ANGPTL6 Accelerates Regeneration of Endothelial Cells Treated with Rapamycin via MAPK Pathways Weizong WangYixin ZhaoYinglong Hou Original Article 12 July 2022 Pages: 13 - 29
Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction Yue-wei LiSi-xu ChenYang-xin Chen Original Article 28 July 2022 Pages: 31 - 41
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction Yang JiJing ChenYun Zhong Original Article Open access 14 September 2022 Pages: 43 - 56
The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding Kim A. ConnellyEllen WuRichard E. Gilbert Original Article 29 September 2022 Pages: 57 - 68
Sulfated Galactofucan from Sargassum Thunbergii Attenuates Atherosclerosis by Suppressing Inflammation Via the TLR4/MyD88/NF-κB Signaling Pathway Kefu ZhuXihao WangLijiang Tang Original Article 04 October 2022 Pages: 69 - 78
Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis Xiaojun ZhuoJian WangLihui Shao Original Article Open access 28 June 2022 Pages: 79 - 89
Effect of Dapagliflozin on the Outcome of Radiofrequency Catheter Ablation in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation Fangyuan LuoLiping SunJianzeng Dong Original Article 13 August 2022 Pages: 91 - 98
Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers Dina M. K. El GindyMohamed H. SolaymanLamia M. El Wakeel Original Article Open access 15 September 2022 Pages: 99 - 108
Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study Rachel EikelboomRichard P. WhitlockEmilie Belley-Cote Original Article 19 September 2022 Pages: 109 - 117
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study Ulrich LaufsAndreas L. BirkenfeldCollaborators in the PERI-DYS Study Original Article Open access 30 September 2022 Pages: 119 - 129
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials S. P. RadhoeE. BoersmaJ. J. Brugts Original Article Open access 04 October 2022 Pages: 131 - 139
Medical Therapy After CABG: the Known Knowns, the Known Unknowns, and the Unknown Unknowns Lauren K. BarronMarc R. Moon Invited Review Article 07 March 2023 Pages: 141 - 149
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review Federico MarchiniGraziella PompeiMatteo Tebaldi Review Article Open access 09 June 2022 Pages: 151 - 161
Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy Oluwabukunmi Modupe SalamiOlive HabimanaGuang-Hui Yi Review Article 15 June 2022 Pages: 163 - 180
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers Muzamil KhawajaJanki ThakkerYochai Birnbaum Review Article 18 June 2022 Pages: 181 - 189
Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a) Robert S. RosensonJ. Antonio G. LópezSantica M. Marcovina Short Communication Open access 26 November 2022 Pages: 191 - 197
The Effect of Colchicine in Acute Myocardial Infarction Chunbo MiaoYanyu LinYingchun Xu Letter to the Editor 02 November 2022 Pages: 199 - 199
Comment on “Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients” Shih-Wei Lai Letter to the Editor 27 November 2023 Pages: 201 - 202
Winding Down the Storm: Could Empagliflozin’s Ion-Dependent Mechanisms Tackle the Ventricular Arrhythmia Burden in Chronic Chagas Cardiomyopathy? Sergio Alejandro Gómez-OchoaLyda Z. RojasLuis Eduardo Echeverría Letter to the Editor 16 October 2023 Pages: 203 - 205